Alterity Therapeutics Ltd - ADR
ATHE
Get informed when a big investor buys or sells
+ FollowMarket Cap$76.4M
Close$
$-0.01
100.1% downside
Current Fair Value
100.1% downsideOvervalued by 100.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $76.40 Million |
|---|---|
| Enterprise Value | $27.35 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.14 |
| Beta | -0.03 |
| Outstanding Shares | 16,966,134 |
Return
| Return on Equity | -39.82% |
|---|---|
| Return on Assets | -37.96% |
| Return on Invested Capital | -50.63% |
Valuation & Multiples
| P/E Ratio | -6.34 |
|---|---|
| PEG | -3.89 |
| Price to Sales | - |
| Price to Book Ratio | 1.51 |
| Enterprise Value to Revenue | 5.03 |
| Enterprise Value to EBIT | -1 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
$-0.12
Average shareholder expectationRevenue Estimate
$2.32 M
Average shareholder expectationNext Earnings Call
Expected Date
March 4, 2027
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$1.20 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.33%▲ 0.43% |
|---|---|
| Total Invested | $2.12M▲ 89.47% |
| Investors Holding | 22▲ 7.00% |
ESG Score
No data
About Alterity Therapeutics Ltd
CEO: Geoffrey Kempler